None
Quote | GENFIT S.A. (NYSE:GNFT)
Last: | $ |
---|---|
Change Percent: | 1.52% |
Open: | $18.00 |
Close: | $18.00 |
High: | $18.10 |
Low: | $17.783 |
Volume: | 47,581 |
Last Trade Date Time: | 02/12/2020 04:40:52 pm |
News | GENFIT S.A. (NYSE:GNFT)
2024-06-11 09:30:02 ET H.C. Wainwright analyst issues BUY recommendation for GNFT on June 11, 2024 07:43AM ET. The previous analyst recommendation was Buy. GNFT was trading at $5.535 at issue of the analyst recommendation. Historical Analyst Recommendations Latest ...
2024-06-07 15:00:58 ET More on the markets Going Into June, SPY Or VXF, Which Is The Better Buy? (Technical Analysis) SPY: 2 Options To Balance Out A Highly Concentrated Index Bitcoin's Fading Action Is A Huge Warning For Stock Market Liquidity Citi – ...
Message Board Posts | GENFIT S.A. (NYSE:GNFT)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
2024-06-11 09:30:02 ET H.C. Wainwright analyst issues BUY recommendation for GNFT on June 11, 2024 07:43AM ET. The previous analyst recommendation was Buy. GNFT was trading at $5.535 at issue of the analyst recommendation. Historical Analyst Recommendations Latest ...
Lakeland Industries Inc. (LAKE) is expected to report $0.3 for Q4 2024 Sekisui House Ltd. ADR (SKHSY) is expected to report for Q4 2024 Hingham Institution for Savings (HIFS) is expected to report for Q1 2024 GENFIT S.A. (GNFT) is expected to report for Q4 2023 Jewett-Cameron Trad...
Seal Rock Therapeutics Announces Out-Licensing Agreement with GENFIT for Development of Injectable Formulation of SRT-015 for Acute-on-Chronic Liver Disease (ACLF) PR Newswire Seal Rock eligible to receive payments up to €100 million, including regulatory, clinical,...